These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24069023)

  • 1. A role for NADPH oxidase in antigen presentation.
    Gardiner GJ; Deffit SN; McLetchie S; Pérez L; Walline CC; Blum JS
    Front Immunol; 2013 Sep; 4():295. PubMed ID: 24069023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.
    Wenger RH; Marti HH; Schuerer-Maly CC; Kvietikova I; Bauer C; Gassmann M; Maly FE
    Blood; 1996 Jan; 87(2):756-61. PubMed ID: 8555500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
    Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
    J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
    Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
    Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocyte NADPH oxidase and specific immunity.
    Cachat J; Deffert C; Hugues S; Krause KH
    Clin Sci (Lond); 2015 May; 128(10):635-48. PubMed ID: 25760962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Granulomatous Disease.
    Roos D
    Methods Mol Biol; 2019; 1982():531-542. PubMed ID: 31172494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the phagocyte NADPH oxidase regulates innate immunity.
    Thomas DC
    Free Radic Biol Med; 2018 Sep; 125():44-52. PubMed ID: 29953922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood.
    Gallin JI
    Int J Tissue React; 1993; 15(3):99-103. PubMed ID: 8188451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-oxidase-containing liposomes.
    Gerber CE; Bruchelt G; Falk UB; Kimpfler A; Hauschild O; Kuçi S; Bächi T; Niethammer D; Schubert R
    Blood; 2001 Nov; 98(10):3097-105. PubMed ID: 11698296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease.
    Dhillon SS; Fattouh R; Elkadri A; Xu W; Murchie R; Walters T; Guo C; Mack D; Huynh HQ; Baksh S; Silverberg MS; Griffiths AM; Snapper SB; Brumell JH; Muise AM
    Gastroenterology; 2014 Sep; 147(3):680-689.e2. PubMed ID: 24931457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired macrophage function following bacterial stimulation in chronic granulomatous disease.
    Rahman FZ; Hayee B; Chee R; Segal AW; Smith AM
    Immunology; 2009 Oct; 128(2):253-9. PubMed ID: 19740382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of chronic granulomatous disease.
    Roos D; de Boer M
    Clin Exp Immunol; 2014 Feb; 175(2):139-49. PubMed ID: 24016250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes.
    de Oliveira-Junior EB; Bustamante J; Newburger PE; Condino-Neto A
    Scand J Immunol; 2011 May; 73(5):420-7. PubMed ID: 21204900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic granulomatous disease.
    Loffredo L
    Intern Emerg Med; 2011 Oct; 6 Suppl 1():125-8. PubMed ID: 22009624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
    J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic, biochemical, and clinical features of chronic granulomatous disease.
    Segal BH; Leto TL; Gallin JI; Malech HL; Holland SM
    Medicine (Baltimore); 2000 May; 79(3):170-200. PubMed ID: 10844936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.
    Köker MY; Sanal O; de Boer M; Tezcan I; Metin A; Tan C; Ersoy F; Roos D
    Eur J Clin Invest; 2006 Apr; 36(4):257-64. PubMed ID: 16620288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox.
    Patiño PJ; Rae J; Noack D; Erickson R; Ding J; de Olarte DG; Curnutte JT
    Blood; 1999 Oct; 94(7):2505-14. PubMed ID: 10498624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
    Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
    Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.